Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Familial abnormalities of endocannabinoid signaling in schizophrenia.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry - 1 Feb 2019

Koethe Dagmar, Pahlisch Franziska, Hellmich Martin, Rohleder Cathrin, Mueller Juliane K, Meyer-Lindenberg Andreas, Torrey E Fuller, Piomelli Daniele, Leweke F Markus

Abstract excerpt

OBJECTIVES: Epidemiological and experimental evidence suggests that the endocannabinoid system plays a pathophysiological role in schizophrenia. This is reflected by elevated cerebrospinal levels of the endocannabinoid anandamide in schizophrenia and its initial prodromal states. METHODS: We analyzed plasma concentrations of anandamide, 2-arachidonoyl-sn-glycerol, palmitoylethanolamide and oleoylethanolamide from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amides
Share to Arachidonic Acids

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Endocannabinoids

Share to Ethanolamines

Share to Palmitic Acids

Share to Polyunsaturated Alkamides

Share to Prodromal Symptoms

Share to Psychotic Disorders

Source

Identifiers

PMID: 29521179
DOI: 10.1080/15622975.2018.1449966

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Familial abnormalities of endocannabinoid signaling in schizophrenia.PMID 29521179Read ↗

Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidenceSemantic proximity Read ↗

Role of cannabis and endocannabinoids in the genesis of schizophrenia.Semantic proximity Read ↗

Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia.Semantic proximity Read ↗

Endocannabinoids Modulate Olfactory System Development and FunctionSemantic proximity Read ↗

Endocannabinoid markers in autism spectrum disorder: A scoping review of human studies.Semantic proximity Read ↗

Association between Arachidonic Acid and the Risk of Schizophrenia: A Cross-National Study and Mendelian Randomization AnalysisSemantic proximity Read ↗

Retrograde Endocannabinoid Signaling Shows Robust Enrichment in Bipolar Disorder: Insights from Standardized Pathway AnalysesSemantic proximity Read ↗

Polymorphisms in SREBF1 and SREBF2, two antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with schizophrenia in German and Scandinavian samples.Semantic proximity Read ↗

Impact of Endocannabinoid System Manipulation on Neurodevelopmental Processes Relevant to Schizophrenia.Semantic proximity Read ↗

A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophreniaSemantic proximity Read ↗

Polyunsaturated fatty acid deficiency during neurodevelopment in mice models the prodromal state of schizophrenia through epigenetic changes in nuclear receptor genesSemantic proximity Read ↗

Endocannabinoid signaling in brain diseases: Emerging relevance of glial cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.